DiA Imaging Earns Clearances for AI Ultrasound Analysis Technologies

DiA Imaging Analysis has received 510(k) clearance from the FDA and the CE mark in Europe for two artificial intelligence (AI)-based ultrasound analysis products.

The company’s LVivo right-ventricle technology can diagnose and monitor right-heart ailments in acute and chronic patients, and its LVivo Bladder product uses AI software to automatically measure bladder volume.

The two products are part of DiA’s LVivo Toolbox, which now includes six AI-powered ultrasound analysis products.